XML 63 R44.htm IDEA: XBRL DOCUMENT v3.25.0.1
Schedule I (Tables)
12 Months Ended
Dec. 31, 2024
Condensed Financial Statements, Captions [Line Items]  
Schedule of Maturities of Long-term Debt [Table Text Block]
Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:
(in millions)
2025$4,548 
20263,756 
20273,531 
20283,106 
20293,656 
Thereafter59,908 
Parent Company [Member]  
Condensed Financial Statements, Captions [Line Items]  
Condensed Balance Sheet [Table Text Block]
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Condensed Balance Sheets
 
(in millions, except per share data)December 31,
2024
December 31,
2023
Assets  
Current assets:  
Cash and cash equivalents$234 $776 
Other current assets411 570 
Total current assets645 1,346 
Equity in net assets of subsidiaries179,209 153,692 
Long-term notes receivable from subsidiaries6,062 5,693 
Other assets920 831 
Total assets$186,836 $161,562 
Liabilities and shareholders’ equity
Current liabilities:
Accounts payable and accrued liabilities
$1,501 $1,116 
Short-term notes payable to subsidiaries2,016 9,887 
Short-term borrowings and current maturities of long-term debt4,348 4,086 
Total current liabilities7,865 15,089 
Long-term debt, less current maturities71,831 57,387 
Long-term notes payable to subsidiaries14,405 — 
Other liabilities77 330 
Total liabilities94,178 72,806 
Commitments and contingencies (Note 4)
Shareholders’ equity:
Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding
— — 
Common stock, $0.01 par value - 3,000 shares authorized; 915 and 924 issued and outstanding
Retained earnings96,036 95,774 
Accumulated other comprehensive loss(3,387)(7,027)
Total UnitedHealth Group shareholders’ equity92,658 88,756 
Total liabilities and shareholders’ equity$186,836 $161,562 
Condensed Statement of Comprehensive Income [Table Text Block]
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Condensed Statements of Comprehensive Income
 
 For the Years Ended December 31,
(in millions)202420232022
Revenues: 
Investment and other income$368 $312 $255 
Total revenues368 312 255 
Operating costs:
Operating costs
108 35 121 
Interest expense
4,544 3,469 2,110 
Total operating costs4,652 3,504 2,231 
Loss before income taxes(4,284)(3,192)(1,976)
Benefit for income taxes1,032 654 429 
Loss of parent company(3,252)(2,538)(1,547)
Equity in undistributed income of subsidiaries17,657 24,919 21,667 
Net earnings14,405 22,381 20,120 
Other comprehensive income (loss) 3,640 1,366 (3,009)
Comprehensive income$18,045 $23,747 $17,111 
Condensed Cash Flow Statement [Table Text Block]
Condensed Financial Information of Registrant
(Parent Company Only)
UnitedHealth Group
Condensed Statements of Cash Flows
 
 For the Years Ended December 31,
(in millions)202420232022
Operating activities 
Cash flows from operating activities$4,852 $17,443 $14,754 
Investing activities
Issuances of notes to subsidiaries(349)(41)(567)
Repayments of notes to subsidiaries225 817 281 
Cash paid for acquisitions and other transactions(13,750)(8,144)(20,728)
Return of capital to parent company21 639 1,424 
Capital contributions to subsidiaries— (2,472)(570)
Cash received from dispositions, net2,444 624 2,787 
Other, net30 286 — 
Cash flows used for investing activities(11,379)(8,291)(17,373)
Financing activities
Common stock repurchases(9,000)(8,000)(7,000)
Proceeds from common stock issuances1,846 1,353 1,253 
Cash dividends paid(7,533)(6,761)(5,991)
(Repayments of) proceeds from short-term borrowings, net(151)11 732 
Proceeds from issuance of long-term debt17,811 6,394 14,819 
Repayments of long-term debt(3,000)(2,125)(3,015)
(Repayments of) proceeds from short-term notes from subsidiaries, net(7,966)1,188 594 
Proceeds from long-term notes from subsidiaries14,396 — — 
Repayments of long-term notes from subsidiaries(28)— — 
Other, net(390)(702)(674)
Cash flows from (used for) financing activities5,985 (8,642)718 
(Decrease) increase in cash and cash equivalents(542)510 (1,901)
Cash and cash equivalents, beginning of period776 266 2,167 
Cash and cash equivalents, end of period$234 $776 $266 
Supplemental cash flow disclosures
Cash paid for interest$4,241 $3,257 $1,969 
Cash paid for income taxes2,450 4,426 4,298 
Schedule of Maturities of Long-term Debt [Table Text Block]
Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:
(in millions)
2025$4,350 
20263,650 
20273,425 
20283,000 
20293,550 
Thereafter59,802